Research Article
Analysis of the Bacterial Spectrum and Key Clinical Factors of Biliary Tract Infection in Patients with Malignant Obstructive Jaundice after PTCD
Table 1
Distribution of pathogenic bacteria in bile samples of patients.
| Species of bacteria | Number of strains () | Constituent ratio | Species of bacteria | Number of strains () | Constituent ratio |
| Gram-negative bacteria | 51 | 54.84% | Gram-positive bacteria | 39 | 41.94% | Escherichia coli | 15 (8 ESBLs) | 16.12% | Enterococcus faecium | 11 | 11.83% | Klebsiella pneumoniae | 12 (3 ESBLs) | 12.90% | Enterococcus faecalis | 5 | 5.38% | Pseudomonas aeruginosa | 6 | 6.45% | Staphylococcus epidermidis | 5 | 5.38% | Stenotrophomonas maltophilia | 5 | 5.38% | Staphylococcus haemolyticus | 4 | 4.30% | Enterobacter aerogenes | 2 | 2.15% | Enterococcus gallinarum | 3 (VRE 1) | 3.23% | Xanthomonas fusca | 1 | 1.08% | Streptococcus angina | 3 | 3.23% | Pseudomonad | 1 | 1.08% | Staphylococcus aureus | 2 (MASA 2) | 2.15% | Proteus mirabilis | 1 | 1.08% | Streptococcus sanguis | 2 | 2.15% | Ochrobactrum anthropi | 1 | 1.08% | Enterococcus durans | 1 | 1.08% | Enterobacter cloacae | 1 | 1.08% | Enterococcus hirae | 1 | 1.08% | Bacillus mucilaginosus | 1 | 1.08% | Staphylococcus cohnii | 1 | 1.08% | Citrobacter brucei | 1 | 1.08% | Enterococcus raffinose | 1 | 1.08% | Klebsiella oxytoca | 1 | 1.08% | Fungus | 3 | 3.23% | Citrobacter freundii | 1 | 1.08% | Candida glabrata | 2 | 2.15% | Acinetobacter ursingii | 1 | 1.08% | Candida krusei | 1 | 1.08% |
|
|